Evidence map›Paper›PMID 40103607›Full record

ArticleExploratory research in clinical and social pharmacy2025

Knowledge, attitude, and practice among community pharmacists toward adverse drug reaction reporting and pharmacovigilance: A nationwide survey.

Tahani Alwidyan, Mohannad Odeh, Ameerah Hasan Ibrahim, Eman Harahsheh, Aya Banat

Abstract read
In one paragraph

Article in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tahani AlwidyanDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Mohannad OdehDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Ameerah Hasan IbrahimDepartment of Pharmacy, Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Amman, Jordan.
Eman HarahshehDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.
Aya BanatDepartment of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa, Jordan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: To enhance the impact of pharmacovigilance on drug safety, it must be integrated into the healthcare system. This study aimed to examine community pharmacists' knowledge, attitudes, and practices regarding adverse drug reaction reporting and pharmacovigilance. Methods: A self-administered, cross-sectional questionnaire study was conducted among eligible community pharmacists between July and September 2023. Participants completed online and paper-based questionnaires after providing prior consent. Descriptive and inferential analyses were performed using the Statistical Package for Social Sciences (SPSS, version 28). One-way ANOVA was used to assess the significance of the association between knowledge, attitude, practice scores, and demographic characteristics. Results: A total of 239 pharmacists completed the questionnaire (response rate of 67.5 %). Of them, 65.3 % were females. Poor knowledge regarding pharmacovigilance was evident in 66.1 % of participants, while only 11 % demonstrated good knowledge. Attitudes were primarily neutral (72.8 %), and practices were categorized as fair for 41.0 % and poor for 31.0 % of pharmacists. Significant factors influencing adverse drug reaction reporting included years of experience ( Conclusion: This study emphasizes the potential enhancement of adverse drug reaction reporting among community pharmacists by addressing poor knowledge, neutral attitudes, and barriers like time constraints. Targeted educational interventions and structured reporting frameworks are essential to enhance pharmacovigilance and ensure medication safety.

Indexed as

Adverse drug reaction reportingAttitudeBarriersCommunity pharmacistsIatrogenic diseaseKnowledgePharmacovigilancePractice

Identifiers

PMID40103607
PMCPMC11919300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.